Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 1 OF 78 | DISPLAYING 1 - 15 OF 1166 RESULTS

    Das K et al., Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue., , Methods Mol Biol, Jan 01, 2020

    Cesano A et al., Status of Immune Oncology: Challenges and Opportunities., , Methods Mol Biol, Jan 01, 2020

    Beechem JM et al., High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-oncology Biomarker Discovery and Translational Research., , Methods Mol Biol, Jan 01, 2020

    Linge A et al., Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC., , Radiother Oncol., Dec 30, 2019

    Chen C et al., Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples, , Oral Oncol., Dec 10, 2019

    You BH et al., HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2, , Proc Natl Acad Sci U S A., Dec 03, 2019

    Baek DW et al., High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer., , J Cancer Res Clin Oncol, Nov 28, 2019

    Croce S et al., The NanoCind® signature is an independent prognosticator of recurrence and death in uterine leiomyosarcomas., , Clin Cancer Res, Nov 26, 2019

    Steinmann S et al., DAPK1 loss triggers tumor invasion in colorectal tumor cells., , Cell Death Dis, Nov 26, 2019

    Creed JH et al., Commercial gene expression tests for prostate cancer prognosis provide paradoxical estimates of race-specific risk, , Cancer Epidemiol Biomarkers Prev, Nov 22, 2019

    Barrow-McGee R et al., Real‐time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study, , J Pathol., Nov 22, 2019

    Dastmalchi F et al., Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling., , J Immunother Cancer, Nov 21, 2019

    Rashid et al., Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer, , Clin Cancer Res, Nov 21, 2019

    Oliver AJ et al., Tissue‐specific tumor microenvironments influence responses to immunotherapies., , Clin Transl Immunology, Nov 21, 2019

    de Medeiros CB et al., Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort, , Cancer Med, Nov 21, 2019